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Purpose/Objective: A joint analysis of data from centres within the 
ISIORT-Europe program was performed to investigate the role of intra-
operative radiotherapy (IORT) and contribute to homogenize 
treatment modalities. 
Materials and Methods: All ISIORT-Europe centres were invited to 
record the data of their IORT treatments using the appropriate file 
available at the website  
www.isiort.org/htm/isiort_europe.htm and send them to the data 
centre. All information (institution, patient data, tumour data, 
treatment modality) were therefore collected in a common database 
to analyse clinical and technical aspects of the treatments. 
Results: Twenty one centers from Italy, Spain, Poland, Austria, 
Germany, France and Israel participated to this survey and data of 
3,769 IORT cases from 1992 to 2012 were collected. Table 1 shows, as 
an example, some technical aspects of the treatment data. 
 
Conclusions: The availability of data from several centres active in 
IORT treatments may allow to perform data analysis useful to 
disseminate knowledge about clinical and technical aspects of this 
radiation modality and to dispose a basis for further clinical 
multicenter trials. 
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Purpose/Objective: Within the last years two types of miniaturized x-
ray sources have become commercially available for radiation therapy 
treatment (RTT) and today about 300 devices are applied in clinics 
worldwide. The two types are manufactured by two different vendors: 
the 'Intrabeam®'-system from Carl Zeiss Meditec AG and the 'Axxent®' 
tube from Xoft (iCad, Inc.). Both devices emit an x-radiation field 
which energy distributionis given by a continuous Bremsstrahlung-
spectrum with a maximum energy of 50keV and characteristic 
fluorescence lines induced by the material of the electron target and 
the materials in the pathway of the emitted photons. Despite this 
similarity the dosimetric and quality assurance procedures are 
different. 
The German National Metrology Institute (PTB) is developing a primary 
standard in terms of absorbed dose to water for miniature x-ray 
sources which does not exist so far. In addition investigations will be 
done in order to find the best method for the dissemination of this 
quantity. As a basis of this work the spatial and energy distribution of 
the radiation fields must be studied. It was reported that the focal 
spot of the X-ray tube shifts with increasing beam current in case of 
the 'Axxent®' tube [1]. To answer the question if this effect arises a 
change of the spectrum spectrometry must be performed at different 
beam currents, also at the maximum beam current. Generally, spectra 
taken at high count rates show typical artefacts such as pulse pile-up 
distortions. In this work an algorithm is presented to consider these 
artefacts in the data evaluation. 
Materials and Methods: Spectra were measured with an HPGe-
Detecor (GLP 0110P, Canberra Industries) in combination with an 
analogue desktop spectrum analyzer (Eagle 5004) featuring pulse pile-
up rejector circuits for high count rate spectrometry. The algorithm to 
eliminatethe remaining pulse-pile up artifacts was developed in 
MATLAB and is based on the approach that by using pile-up rejector 
circuits the remaining artifacts are given by a single or multiple 
convolution of the primary spectrum with itself. 
Results: In Figure 1 three spectra of the 'Axxent®'tube taken at 50 kV 
tube voltages are presented. The spectrum measured at 300 µA beam 
current is given in a black dash-dotted line. The count rate during the 
measurement was more than 160000 Cts/s and the dead time of the 
spectrometry system was more than 65%. The spectrum shows 
significant pulse pile-up artefacts, clearly visible at photon energies 
above 50 keV. The spectrum reconstructed from the first one with the 
developed algorithm is given in full red line. For comparison, a 
spectrum measured at 10 µA beam current is shown in blue dashed 
line. 
 
  
Conclusions: The spectrum reconstructed by means of the developed 
algorithm matches the spectrum taken at 10 µA. These findings 
assume to support the following conclusions: first the proposed 
algorithm works properly and second the spectra of the tube don't 
alter with varying beam currents. 
[1] P. Sievers, et al. 41. DGMP Annual Meeting, Freiburg im Br. 29. 09. 
– 02.10.2010, Germany 
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Purpose/Objective: Intra-operative radiotherapy (IORT) is an 
investigational approach for the treatment of locally advanced 
prostate cancer. The aim of this study is to analyze clinical, technical 
and organizational parameters to optimize the IORT procedure at our 
Institution. 
Materials and Methods: In 2005, a program for IORT in high risk, 
locally advanced prostate cancer started at our Institution as 
anticipated boost for a dose of 12 Gy. The following clinical, technical 
and organizational parameters were defined for quality assurance 
(QA): 
- multidisciplinary discussion by a dedicated staff, 
- patients age < 76 years, probability of organ-confined disease < 25% 
according to MSKCC nomogram, KPS > 90, 
- pre-surgical staging with bone scan and pelvic CT and/or MRI,  
- specific informed consensus,  
- complications assessment, 
- measurement of prostate anterior-posterior (A-P) and transverse 
diameters on pre-surgical imaging and intra-operative ultrasound to 
define the electron beam energy, 
- 'in vivo' rectal dose detection by 4 radio-chromic films positioned on 
a rectal probe, 
- collimator diameter choose based on pre-operative imaging and on 
target identification directly in the surgical field, 
- target including prostate plus a circumferential margin (0.5 cm), 
- bevel angle (range 0°-30°) adapted on pubic arc anatomy and 
prostate exposure, 
- multidisciplinary meeting for timing and technical details,  
- evaluation of the procedure duration.  
Results: Until July 2012, 84 patients were selected for IORT and 100% 
of them accepted the procedure. Median age was 68 years (range 52-
76). Median iPSA was 14.6 ng/ml (range 2.0-63.9) and median GS was 
8 (range 4-10); 64/84 met the selection criteria regarding the organ-
confined disease. No major intra or post-operative complications 
occurred; 70% of patients required transfusion. We observed minor 
complications in 13/84 cases (15.5%) (lymphoceles, urethral-bladder 
anastomosis, strictures, pelvic haematomas). Median dose to the 
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anterior rectal wall was 4.45 Gy (range 0.06-11.3). Median A-P and 
transverse diameter measured on pre-operative CT were 40 mm 
(range 27-60) and 50 mm (range 35-67) respectively. Median A-P 
diameters on intra-operative ultrasound were 30 mm (range 22-43) 
and 32 mm (range 24-47) with and without prostate compression, 
respectively. The most used collimator (41.6%) had a 5.5 cm diameter 
(range 4.5–7). A bevel angle of 30° was used in 96.4% of cases; 9 and 
12 MeV beam energy were used in 50% of cases, respectively. All cases 
were discussed in a multidisciplinary meeting. IORT procedure lasted 
30' in average (range 15-45). 
Conclusions: The definition of a program of QA was useful in such a 
multidisciplinary and complex procedure as IORT. The increasing 
expertise of the staff over time allowed to optimize the procedure 
that resulted feasible and safe.  
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Purpose/Objective: To compare Radiochromic films and MOSFET 
measurements with Monte Carlo simulation in RW3 slab phantom with 
air gap in order to analyze overdosage measured with MOSFET during 
intraoperative electron radiotherapy in breast cancer treatment. 
Materials and Methods: Patients affected by early-stage breast 
cancer underwent IOERT, treatments were performed using a mobile 
Linear accelerator (4, 6, 8, 10 MeV electron beams; LIAC, Sordina 
S.p.A., Italy). Dose was prescribed at the deeper part of the target 
normalized at 90%. MOSFET (BestMedical, Canada) detectors, placed 
inside a sterile catheter, fixed at the centre of the PTFE side of a 
shielding disk used to minimize the thoracic wall irradiation, were 
used in clinical routine to determine the dose collected by the deeper 
part of the target. Readings at half treatment in the 18% of cases are 
higher than 10%. Our hypothesis is that air gaps and non homogeneous 
tissues can create high dose hot spot in the irradiated glandular 
tissue. We have first simulate air gap and non homogeneous tissue 
using a filled water glove and a dose calibrated GAFCHROMIC® MD-V2-
55 radiochromic film interposed between the glove and the PTFE 
plate, the air gap is between two 'fingers',then as a second step, to 
have a reproducible set-up, we have used a RW3 slab phantom with 
variable air gaps: high range: 0.5 - 1 cm and large range: 0.2-0.5 cm 
with the film interposed in the same way. Monte Carlo simulation 
(EGSnrc/BEAMnrccode, 1 mm simulation step, voxel dimension 
1x5mmx29mm) has been utilized with an gap 1 cm high and 0.2 and 
0.5 cm large. 
Results: MD-V2-55 film interposed between glove and PTFE disk shows 
overdosages until 15% in the interface between water and air, the 
same values were found with RW3 slab phantom and with Monte Carlo 
simulation. Figure1A shows MD-V2-55 profiles obtained in phantom at 
different air gap dimension and Figure1B shows Monte Carlo 
simulation profile with the same phantom, the peak is 14% high. 
 
  
Conclusions: Monte Carlo simulation and MD-V2-55GAFCHROMIC® film 
measurements might confirm that overdosage measured during IOERT 
breast cancer treatment might be due to nonhomogeneous tissues and 
air gaps, the next step will be to used MD-V2-55 GAFCHROMIC® film in 
vivo during IOERT to investigate dose distribution along the irradiated 
volume. 
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Purpose/Objective: To check accuracy and uniformity of the dose 
delivered to the breast lumpectomy target during intraoperative 
electron beam radiotherapy (IOERT): we analyzed and compared 
radiochromic film and MOSFET reading in a sample of 19 patients. 
Materials and Methods: 459 patients affected by early-stage breast 
cancer underwent IOERT, treatments were performed using a mobile 
Linear accelerator (4, 6, 8, 10 MeV electron beams; LIAC, Sordina 
S.p.A., Italy),using cylindrical applicators and steel-PTFE plates 
(3mm+3mm) placed between the residual breast and the pectoralis 
muscle to minimize the thoracic wall irradiation. Dose was prescribed 
at the deeper part of the target normalized at 90%. MOSFET (Best 
Medical, Canada) detectors, placed inside a sterile catheter, fixed at 
the centre of the PTFE side of the shielding disk, were used in clinical 
routine to determine the dose collected by the deeper part of the 
target. Delivered dose is divided in two parts and monitor unit are 
corrected if MOSFET reading exceed 10% of prescribed dose. Readings 
at half treatment in the 18% of cases are higher than 10%, therefore in 
a sample of 19 patient, in order to analyse dose uniformity along the 
target, a GAFCHROMIC® MD-V2-55 radiochromic film was interposed 
between MOSFET and shielding disk. The two detectors were 
calibrated at theLinac electron beam energies in the same geometry 
of daily dosimetry check. MD-V2_55 2D profile are acquired in region 
clearly patchy to determine: hot spot 2D dimension (width at half 
height) and hot spot value (HSV) defined as the % difference between 
expected dose and the mean between the maximum dose found in the 
hot spot and the respective 95%; HSV has been defined considering 
that dose prescription is assigned at R90, therefore a plus 10% in dose 
values is get in.  
Results: 6/19 (31%) of GAFCHROMIC® MD-55 exposed films have shown 
occasional hot spot regions with values higher than 15%, Figure1 
shows an example of exposed film and Table1 analysed HSV, hot spot 
size and taken up percentage of film size .HSV mean values: 26+2 Gy, 
mean size 1.4 +0.3cm2 and mean percentage between hot spot size 
and the corresponding irradiated film is 7.6%. 
 
 
  
